Ticker: DTIL

Company Overview Precision BioSciences, Inc. (NASDAQ: DTIL) is a clinical stage gene editing company that is focused on developing transformative in vivo therapies using its proprietary ARCUS genome editing platform. The company is currently advancing several gene editing programs targeting rare ...